Patent intelligence · US
US 10973841
Compositions for the treatment of skin conditions
Compositions for the treatment of skin conditions
Patent details — US 10973841
- Jurisdiction
- US
- Status
- granted
- Grant date
- Apr 13, 2021
- Expiration
- Apr 8, 2041
- Applicant
- FORTE SUBSIDIARY, INC.
- Claims
- 17
- CPC classes
- A61K, A61K31/121, A61K31/16, A61K31/201
Quick answer
US 10973841 (Compositions for the treatment of skin conditions) is held by FORTE SUBSIDIARY, INC.. Status: granted. Granted Apr 13, 2021. Expires Apr 8, 2041 (15 years remaining) — relevant for patent-cliff and LOE planning.
Key facts
- Applicant
- FORTE SUBSIDIARY, INC.
- Grant date
- Expiration
- Claims
- 17
- CPC classes
- A61K, A61K31/121, A61K31/16, A61K31/201, A61K31/336, A61K31/565
More from FORTE SUBSIDIARY, INC.
Related pharmaceutical patents in our USPTO index.
Frequently asked questions
What is US patent 10973841?
US 10973841 (Compositions for the treatment of skin conditions) is held by FORTE SUBSIDIARY, INC.. Status: granted. Granted Apr 13, 2021. Expires Apr 8, 2041 (15 years remaining) — relevant for patent-cliff and LOE planning.
Who owns US 10973841?
FORTE SUBSIDIARY, INC. is listed as the applicant in USPTO PatentsView records indexed by NovaPharmaNews. We track 3 pharmaceutical patents for this assignee.
When does US 10973841 expire?
Our index shows an expiration date of Apr 8, 2041 (15 years from today). Confirm material dates against USPTO, FDA Orange Book, or qualified counsel before contractual decisions.